PTC
PTC
PTC
A recent news headline notes: "PTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026". Against this background, PTC Inc reports a market cap of 15,114,814,844 and annual revenue of 2,739,226,000. The company also demonstrates an EPS TTM of 10.67183480558438, a PE ratio of 12.61271676300578, and a free cash flow yield of 6.189185971876798%.
Based on prnewswire.comPTC Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, Oct. 29, 2026
PTC Announces Servigistics Renewal with U.S. Air Force
Are BWIN, PTC, FULC, PRTH Obtaining Fair Deals for their Shareholders?
Are BWIN, PTC, FULC, PRTH Obtaining Fair Deals for their Shareholders?
Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
Halper Sadeh LLC is Investigating Whether PTC and OPCH are Obtaining Fair Deals for their Shareholders
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.